Lessons from FDA 483s and cGMP Inspection DataByAjay Pazhayattil,Naheed Sayeed,Marzena IngramDecember 15th 2019Production and process controls, organization and personnel were the top problems found, while packaging and labeling citations increased in 2017 and 2018.